Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000244942 | SCV000318257 | likely benign | Cardiovascular phenotype | 2017-04-28 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001722368 | SCV000522148 | likely benign | not provided | 2019-03-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000534152 | SCV000638399 | benign | Hypertrophic cardiomyopathy 10 | 2024-12-23 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000777833 | SCV000913832 | benign | Cardiomyopathy | 2018-04-28 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV003999015 | SCV004845813 | benign | Hypertrophic cardiomyopathy | 2023-12-13 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV001729497 | SCV001978947 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001722368 | SCV001980467 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004535215 | SCV004711726 | likely benign | MYL2-related disorder | 2020-08-24 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |